EyePoint Pharmaceuticals reported its fourth-quarter 2024 financial results, revealing a mixed performance with a revenue beat but an EPS miss. The company posted a net revenue of $11.6 million ...
EyePoint Pharmaceuticals reported its fourth-quarter 2024 financial results, revealing a mixed performance with a revenue beat but an EPS miss. The company posted a net revenue of $11.6 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback